NCT06962995

Multi-Cancer Detection Observational Cohort Study

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 500 (estimated)
• Sponsor: Mayo Clinic · Academic / Other
• Sex: All
• Age: 21 Years
• Healthy volunteers: Accepted

Summary

This study assesses the incorporation of Multi-Cancer Detection (MCD) testing, designed to detect many types of cancer, into clinical practice to understand both its use and effect in real world practice conditions.

Conditions

• Cancer

Interventions

Type	Name	Description
PROCEDURE	Blood Sample	Up to 60 mL (about 4-5 Tbsp) of blood may be collected for an initial blood draw and up to 30 mL (about 2-3 Tbsp) may be collected for a second blood draw, 25-45 days after first blood draw. The research blood will be collected at the time of a clinical blood draw, if possible.
OTHER	Surveys	Participants will complete surveys related to attitudes and beliefs around Multi-Cancer Detection testing.

Timeline

• Start date: 2025-05-07
• Primary completion: 2029-06-30
• Completion: 2029-06-30
• First posted: 2025-05-08
• Last updated: 2026-04-06

Locations

3 sites across 1 country: United States